Group One Trading’s Denali Therapeutics DNLI Stock Holding History

Group One Trading’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20K	Buy	+776	New	+$15.9K	﹤0.01%	6025
2024 Q4	–	Sell	-1,691	Closed	-$43.3K	–	7414
2024 Q3	$49.3K	Buy	+1,691	New	+$41.9K	﹤0.01%	4660
2024 Q2	–	Sell	-8,455	Closed	-$162K	–	6878
2024 Q1	$173K	Buy	+8,455	New	+$159K	﹤0.01%	3688
2023 Q2	–	Sell	-49,760	Closed	-$1.4M	–	7752
2023 Q1	$1.15M	Buy	+49,760	New	+$1.37M	﹤0.01%	2019
2022 Q3	–	Sell	-3,522	Closed	-$115K	–	7661
2022 Q2	$104K	Sell	3,522 -3,437	-49%	-$90K	﹤0.01%	4948
2022 Q1	$224K	Sell	6,959 -7,386	-51%	-$254K	﹤0.01%	4683
2021 Q4	$640K	Buy	+14,345	New	+$680K	﹤0.01%	3842
2021 Q3	–	Sell	-1,193	Closed	-$67.2K	–	8284
2021 Q2	$94K	Buy	+1,193	New	+$73.8K	﹤0.01%	6025
2020 Q2	–	Sell	-5,756	Closed	-$135K	–	5855
2020 Q1	$101K	Buy	+5,756	New	+$120K	﹤0.01%	3287
2019 Q4	–	Sell	-2,200	Closed	-$36.6K	–	5197
2019 Q3	$34K	Buy	+2,200	New	+$42K	﹤0.01%	4159
2019 Q1	–	Sell	-100	Closed	-$2.09K	–	4918
2018 Q4	$2K	Buy	+100	New	+$1.81K	﹤0.01%	4649

Other funds holding DNLI

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading's DNLI Position: Q2 2026 in Review

Group One Trading opened a new position in Denali Therapeutics (DNLI) in Q2 2026: 776 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #6025 among its holdings. This is a return to the name: Group One Trading previously reported a position in DNLI as recently as Q3 2024.

Group One Trading first reported a position in DNLI in Q4 2018 and has held it in 11 quarters since. The position peaked at $1.15M in Q1 2023. 294 funds tracked by Wall St. Rank hold DNLI as of Q2 2026.

Group One Trading held 776 shares of Denali Therapeutics worth $20K as of Q2 2026.
Denali Therapeutics was a new Group One Trading position in Q2 2026.
Denali Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6025 holding.
Group One Trading first reported a position in Denali Therapeutics in Q4 2018 and has held it in 11 quarters since.
Group One Trading's Denali Therapeutics position peaked at $1.15M in Q1 2023.
294 funds tracked by Wall St. Rank held Denali Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.